We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $3.01B
1-Year Est. Return 119.46%
This Fund
S&P 500
This Quarter Est. Return
+19.85%
1 Year Est. Return
+119.46%
3 Year Est. Return
+340.9%
5 Year Est. Return
+347.01%
10 Year Est. Return
+3,143.27%
AUM
$3.01B
AUM Growth
+$299M
Cap. Flow
-$137M
Cap. Flow %
-4.54%
Top 10 Hldgs %
41.28%
Holding
178
New
26
Increased
27
Reduced
43
Closed
23

Top Buys

Rank Stock Value
1
ADMA icon
ADMA Biologics
ADMA
+$21.5M
2
ADCT icon
ADC Therapeutics
ADCT
+$19.6M
3
PLNT icon
Planet Fitness
PLNT
+$16.4M
4
FULC icon
Fulcrum Therapeutics
FULC
+$14.8M
5
IVA
Inventiva
IVA
+$12.9M

Top Sells

Rank Stock Value
1
SLNO
Soleno Therapeutics
SLNO
+$58.4M
2
PTON icon
Peloton Interactive
PTON
+$37.2M
3
ESTA icon
Establishment Labs
ESTA
+$35.7M
4
HGV icon
Hilton Grand Vacations
HGV
+$23.2M
5
TNGX icon
Tango Therapeutics
TNGX
+$18.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 45.89%
2 Healthcare 33.86%
3 Consumer Discretionary 8.42%
4 Financials 4.15%
5 Communication Services 2.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITGR icon
76
Integer Holdings
ITGR
$4.29B
$10.4M 0.35%
111,302
-60,698
-35% -$5.39M
IVA
77
Inventiva
IVA
$978M
$10.2M 0.34%
+2,686,393
New +$12.9M
ILPT
78
Industrial Logistics Properties Trust
ILPT
$520M
$9.86M 0.33%
1,111,153
-567,820
-34% -$4.4M
DUOL icon
79
Duolingo
DUOL
$6.72B
$9.65M 0.32%
83,877
-16,123
-16% -$1.76M
RSVR
80
Reservoir Media
RSVR
$601M
$9.31M 0.31%
940,960
– –
SVC
81
Service Properties Trust
SVC
$892M
$9M 0.3%
1,064,528
-347,049
-25% -$2.73M
GUTS icon
82
Fractyl Health
GUTS
$104M
$8.97M 0.3%
11,289,096
-2,075,423
-16% -$1.48M
DHX icon
83
DHI Group
DHX
$202M
$8.81M 0.29%
2,374,027
– –
AMLX icon
84
Amylyx Pharmaceuticals
AMLX
$3.64B
$8.74M 0.29%
486,684
-49,000
-9% -$758K
KRRO icon
85
Korro Bio
KRRO
$194M
$8.7M 0.29%
660,036
– –
ALEC icon
86
Alector
ALEC
$229M
$8.68M 0.29%
4,318,109
+1,502,126
+53% +$3.22M
NDLS icon
87
Noodles & Co
NDLS
$86M
$8.28M 0.27%
553,746
– –
RH icon
88
CALL
RH
RH
$2.58B
$8.24M 0.27%
50,000
– –
CDXS icon
89
Codexis
CDXS
$157M
$8.19M 0.27%
3,623,613
-500,000
-12% -$1.24M
CATX icon
90
Perspective Therapeutics
CATX
$313M
$7.93M 0.26%
+2,325,450
New +$8.79M
TBBK icon
91
CALL
The Bancorp
TBBK
$2.05B
$7.88M 0.26%
125,800
– –
IACQU
92
Irenic Acquisition Corp Unit
IACQU
$227M
$7.62M 0.25%
+750,000
New +$7.55M
QURE icon
93
PUT
uniQure
QURE
$3.11B
$7.44M 0.25%
+161,500
New +$4.23M
DMRA
94
Damora Therapeutics
DMRA
$1.73B
$7.23M 0.24%
278,000
– –
VMD icon
95
Viemed Healthcare
VMD
$334M
$7.21M 0.24%
632,445
-251,338
-28% -$2.49M
UNCY icon
96
Unicycive Therapeutics
UNCY
$146M
$6.57M 0.22%
1,401,447
+462,245
+49% +$3.41M
COOK icon
97
Traeger
COOK
$136M
$6.53M 0.22%
82,831
-19,577
-19% -$1.02M
FORR icon
98
Forrester Research
FORR
$228M
$6.42M 0.21%
763,446
+69,024
+10% +$451K
ABEO icon
99
CALL
Abeona Therapeutics
ABEO
$315M
$6.3M 0.21%
1,020,000
– –
LXEO icon
100
Lexeo Therapeutics
LXEO
$359M
$6.05M 0.2%
1,300,000
+100,000
+8% +$541K
2 3
4
5 6

Similar funds

MYLI
Meiji Yasuda Life Insurance Tokyo, Japan $3.01B AUM 7.86% 1-Year Est. Return
SIC
Schwartz Investment Counsel Plymouth, Michigan $3.01B AUM 27.22% 1-Year Est. Return
HFM
Harvest Fund Management Beijing, China $3.02B AUM 91.56% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return
HP
Hosking Partners London, United Kingdom $3.01B AUM 83.99% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return
SI
Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return

Nantahala Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Nantahala Capital Management held 178 positions worth $3.01B, up 11% from $2.72B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Nantahala Capital Management withdrew a net $137M in Q2 2026, closing 23 positions and reducing 43 holdings. Its most notable exit was Soleno Therapeutics, an estimated $58.4M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 42% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Nantahala Capital Management opened a new position in ADMA Biologics worth $19.8M.

  • Nantahala Capital Management's largest Q2 2026 buy was ADMA Biologics: 2,359,993 shares worth $19.8M.
  • Nantahala Capital Management added most to ADC Therapeutics in Q2 2026, an estimated $19.6M increase.
  • Nantahala Capital Management's biggest Q2 2026 reduction was Peloton Interactive, cutting an estimated $37.2M.
  • Nantahala Capital Management fully exited Soleno Therapeutics in Q2 2026, selling an estimated $58.4M.
  • Nantahala Capital Management's ten largest holdings make up 41% of its $3.01B portfolio in Q2 2026.
  • Nantahala Capital Management opened 26 new positions and closed 23 in Q2 2026.
  • Nantahala Capital Management's portfolio value rose 11% quarter-over-quarter to $3.01B.

Based on Nantahala Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.